ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
This study has been withdrawn prior to enrollment.
(Lack of accrual)
Tulane University Health Sciences Center
Board of Regents, State of Louisiana
Information provided by (Responsible Party):
Bridgette Collins-Burow, Tulane University
First received: October 9, 2009
Last updated: March 9, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||December 2010|
|Primary Completion Date:||September 2010 (Final data collection date for primary outcome measure)|